The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lauer Regan J since 2006.
This trader's CIK number is 1200637.
At the time of last reporting, Lauer Regan J was the Chief Accounting Officer of Immunitybio, Inc.. (stock ticker symbol IBRX).
Also see all insider trading activities at Immunitybio, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2007 | FPTB | 0 | $0 | 5,102 | $139,365 | 5,102 | $87,703 |
2006 | FPTB | 0 | $0 | 4,159 | $121,530 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | IBRX | 0 | $0 | 0 | $0 | 4,065 | $0 |
2024 | IBRX | 0 | $0 | 0 | $0 | 53,903 | $0 |
2023 | IBRX | 0 | $0 | 0 | $0 | 74,932 | $0 |
1. Banc Of California, Inc. (FPTB)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2007-03-09 | FPTB | Option Ex | 1,500 | 17.19 | 25,785 |
2007-03-09 | FPTB | Sale | 1,500 | 27.01 | 40,516 |
2007-03-07 | FPTB | Option Ex | 2,602 | 17.19 | 44,728 |
2007-03-07 | FPTB | Sale | 2,602 | 27.32 | 71,086 |
2007-03-05 | FPTB | Sale | 1,000 | 27.76 | 27,763 |
2007-03-05 | FPTB | Option Ex | 1,000 | 17.19 | 17,190 |
2006-05-22 | FPTB | Sale | 2,600 | 29.00 | 75,400 |
2006-05-15 | FPTB | Sale | 1,559 | 29.59 | 46,130 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-02-22 | IBRX | Option Ex | 4,065 | .00 | 0 |
2024-12-15 | IBRX | Option Ex | 21,031 | .00 | 0 |
2024-01-31 | IBRX | Option Ex | 32,872 | .00 | 0 |
2023-12-15 | IBRX | Option Ex | 21,030 | .00 | 0 |
2023-09-01 | IBRX | Option Ex | 32,872 | .00 | 0 |
2023-06-15 | IBRX | Option Ex | 21,030 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lauer Regan J (Chief Accounting Officer of Immunitybio, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.